See SVHC listings before they land.

Jungle tracks ECHA's CLH pipeline and scores how close each of your substances is to those already listed, so you can reformulate in time.

14,000+Substances monitored
6.7xAgreement with the ChemSec SIN List, top 100

From substance list to risk report in four steps.

01 //

Send your list

Your substances with CAS numbers.

02 //

Hazard mapping

Each one is placed on the ECHA hazard graph: 14,000+ substances, all GHS classifications.

03 //

Risk scoring

Substances close to listed SVHCs get a risk score, weighted by how rare the shared hazards are.

04 //

Risk report

A ranked list with listing band, estimated window and reformulation priority.

What a screen looks like.

An illustrative output. The score reflects how close a substance is to confirmed SVHCs through shared, rare hazards, not a count of hazard flags.

SubstanceCASRisk ScoreListing BandEst. WindowKey Shared Endpoints
6:2 Fluorotelomer sulfonate27619-97-2
0.91
HIGH0-12 moPBT, vPvB, aquatic chronic Cat.1
Bisphenol F620-92-8
0.85
HIGH0-12 moEndocrine disruption, Repr. Cat.1B
Chlorinated paraffins C14-1785535-85-9
0.79
HIGH12-18 moPBT, vPvB, aquatic chronic
Diisopentyl phthalate605-50-5
0.73
MEDIUM12-24 moRepr. Cat.1B, endocrine disruption
Phenol, methylstyrenated68512-30-1
0.68
MEDIUM18-24 moAquatic chronic Cat.1, CMR
Tris(2-chloroethyl) phosphate115-96-8
0.61
MEDIUM18-30 moCarc. Cat.2, CMR screening trigger
2-Ethylhexyl acrylate103-11-7
0.38
LOW24+ moSkin sens. Cat.1, aquatic chronic
Isopropanol67-63-0
0.14
LOW24+ moFlam. liq. Cat.2 only

ILLUSTRATIVE OUTPUT: representative examples. Client screens run against the full REACH C&L inventory. Not regulatory advice.

Tested against history.

Run at six historical cutoffs between 2016 and 2021, trained only on listings before each date and checked against what was listed afterwards. Covers CMR-pathway substances; PBT and vPvB listings are outside scope.

5–9×

Above random in priority screening (Recall@2000), ahead of H-code counting in every validation window.

17–36 mo

Typical time from CLH consultation opening to Candidate List addition for CMR-pathway substances, from ECHA's published pipeline data.

6.7×

Agreement with the ChemSec SIN List in the top 100 predictions, an independent benchmark the model never saw in training.

What you receive.

Substance Risk Screen

  • Structural risk score per substance
  • Shared hazard endpoints with SVHC-listed compounds
  • Listing probability band: HIGH / MEDIUM / LOW
  • Estimated listing window: 0-12 / 12-24 / 24+ months
  • Biannual delta update on ECHA publication cycles

Reformulation Intelligence

  • Most structurally similar listed SVHCs per high-risk compound
  • Recommended substitution and reformulation lead time
  • Supply chain disruption risk assessment per substance
  • Prioritised substitution order by listing window
  • Alert subscription: triggered at each ECHA biannual cycle

For teams managing large REACH portfolios.

Chemical procurement teams

Automotive, electronics, aerospace, pharma manufacturers running 50 to 500+ substance portfolios.

EHS & regulatory affairs

In-house teams that currently monitor ECHA manually every biannual publication cycle.

Specialty distributors & suppliers

Chemical distributors managing downstream exposure across diverse customer portfolios.

ESG & supply chain due diligence

Firms conducting supplier screening, PE due diligence, or ESG risk audits with chemical exposure components.

Method

Scores come from a graph model of ECHA's public hazard endpoint data and PubChem GHS classifications. CLH consultation stages come from ECHA's public pipeline export. All inputs are public REACH and GHS data.

Limits

Most reliable for CMR substances (carcinogenic, mutagenic, reprotoxic). PBT and vPvB substances may score lower than their real risk, because environmental persistence is not captured. Outputs are risk intelligence, not regulatory or compliance advice.

Screen your substance portfolio.

Send your substance list. We return a ranked report within 5 business days.